{"brief_title": "Alternate Day Buprenorphine Administration, Phase IX - 14", "brief_summary": "The purpose of this study is to determine if four times a subjects' daily maintenance dose will hold for 120 hours without changes in agonist and antagonist effects.", "condition": ["Opioid-Related Disorders"], "intervention_type": ["Drug"], "intervention_name": ["Buprenorphine"], "criteria": "Please contact site for information.", "gender": "All", "minimum_age": "22 Years", "maximum_age": "51 Years", "healthy_volunteers": "No", "mesh_term": ["Opioid-Related Disorders", "Buprenorphine"], "id": "NCT00000232"}